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The authors are correct that there is much more information to be
gleaned from our data and we appreciate their input. We chose to
present the most clinically relevant information to the readership of
Journal of Arthroplasty and to stimulate a discussion about the interaction
between instruments used in TKA surgery, patient anatomy and surgical
accuracy. Nonetheless, we hope this dataset can be helpful in designing
more in depth anatomic studies of arthritic knees.
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Comment on: “Diagnosis of Periprosthetic Joint
Infection: The Role of Nuclear Medicine May Be
Overestimated” by Claudio Diaz-Ledezma, Courtney
Lamberton, Paul Lichtstein and Javad Parvizi
To the Editor:
We read with interest the article by Diaz-Ledezma et al entitled
“Diagnosis of Periprosthetic Joint Infection: The Role of Nuclear
Medicine May Be Overestimated” recently published in The Journal of
Arthroplasty [1].
We agree with the authors that an accurate and efficient diagnosis of
prosthetic joint infection (PJI) is a challenge and of invaluable importance
for the patient and for the whole medical community, since PJI leads to a
highmorbidity and a significant increase infinancial costs [2]. The aims of
the Infection and Inflammation Committee of the European Association
of Nuclear Medicine (EANM) are to develop clear interpretation criteria
for the various existing nuclearmedicine techniques, to teach each centre
how to correctly acquire and interpret the images and to develop, in
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collaboration with other societies, common diagnostic flow charts to
state clearly to the clinician what we can offer and at which time point
in the diagnostic work-up of the patient.
The article by Diaz-Ledezma et al raised some concerns to us, since
some interpretations they made need to be clarified.
First of all, the authors state in the first paragraph that two
workgroups “could not find concrete evidence in support of using bone
scan or nuclear imaging for diagnosis of PJI”. This sentence is misleading
since most of the published systematic reviews agree on the role of
nuclear medicine, and particularly with the high diagnostic accuracy of
scintigraphy with radiolabelled white blood cells (WBC) [3–5]. Also a
largeworkgroupwith both imaging specialists andorthopaedic surgeons
conducted a critical appraisal of studies reporting the accuracy of nuclear
imaging for diagnosis of PJI by using the QUADAS-2 tool and recom-
mended, based on their findings, that there is substantial evidence
regarding the effectiveness of nuclear imaging in diagnosing PJI,
although it should be limited to select cases [6].
Later on, they state that “there is a dire need for further evidence
to support the use of this otherwise invasive and relatively expensive
diagnostic modality”. We would like to emphasise that nuclear medi-
cine procedures are non-invasive and non-expensive as compared to
other diagnostic modalities.
Furthermore, authors included in their analysis studies performed
with 67Gallium-citrate, radiolabelled white blood cells (WBC) and
radiolabelled anti-granulocyte antibodies. These methods cannot be
pooled together since they have different diagnostic accuracies and
different indications.
In general, there are two strategies for using nuclear medicine tech-
niques in PJI: (1) Use the bone scan with radiolabelled diphosphonates
to see if there is an increased osteoblastic activity. It is universally
accepted that a normal bone scan can be considered as a strong evi-
dence against the presence of an infection. However, a positive bone
scan cannot distinguish infections fromother bone inflammatory condi-
tions and therefore a positive bone scan is aspecific. To further clarify
when this technique should be used, one has to keep in mind that a
bone scan may be positive for at least 2 years after hip prosthesis place-
ment and 5 years after knee prosthesis placement due to physiological
bone re-modelling after implantation. During these intervals, the bone
scan should not be used as a first imaging technique. (2) Use radiophar-
maceuticals that are able to image infection. The first nuclear imaging
modality of choice is based on the use of radiolabelled autologous
WBC. When using the correct acquisition and interpretation criteria
this technique has a high diagnostic accuracy (N90%). The scintigraphy
with radiolabelled anti-granulocyte antibodies can be used as an alter-
native to WBC-scintigraphy in centres that are not able to label the
autologouswhite blood cells. 67Gallium scintigraphy – one of the search
criteria in this study! – is an obsolete technique that is outperformed
by other techniques and should not be used anymore for diagnos-
ing PJI. Another imaging technique that is frequently used in PJI is
18F-fluorodeoxyglucose for positron emission tomography (FDG-PET)
which is not mentioned at all by the authors.
To our regret, the studies included in the paper of Diaz-Ledezma et al
show a huge variety of radiopharmaceuticals but not always the correct
ones used in modern nuclear medicine.
Another striking concern is the timeframe for inclusion of the studies
(January 1, 2004 till July 31, 2012). On the contrary, in the discussion a
paper from 2014 is discussed that states that nuclear medicine studies
should be abandoned as a first diagnostic approach for PJI. In the last
years there has been a huge development innuclearmedicine techniques.
Not only better camera systems were developed, they were also hybrid
systems, which made it possible to perform 3D images of the patient
and to exactly localise the pathological uptake of any radiopharmaceutical
(combining pathophysiology with anatomy, the so called SPECT-CT)
leading to high diagnostic accuracy. Furthermore, several studies have
recently been published for WBC scintigraphy, focusing on how to
correctly acquire the images and how to correctly interpret the scans.
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When following these strategies, diagnostic accuracy is N93% [7,8].Most
of the papers analysed by Diaz-Ledezma et al have not used a correct
imaging protocol or standardised interpretation criteria. SPECT/CT
should be performed for a more detailed localisation ofWBC accumula-
tion, particularly for differentiating between osteomyelitis and soft
tissue infection.
We agree that it is very important to compare the results of the
imaging techniques with correct reference standards like given by
the IDSA and AAOS [9,10]. This should be pathology and/or micro-
biology, or at least a thorough clinical follow-up time of at least six
months. Of course, scans have to be performed at a predefined time
point in the diagnostic work-up of the patient and at the same time
point as other diagnostic procedures to reliably compare the results
of the different techniques with each other. We don’t know exactly
if and how the use of steroids and/or antibiotics influences
the uptake of e.g. the labelled white blood cells. To overcome these
limitations, we (not only nuclear medicine specialists but also sur-
geons and the whole medical community) are in need of prospective
randomised trials to finally get evidence based data for the use of the
different techniques.
In our opinion and supported by most recently published evidence,
when using the correct acquisition protocols, the correct interpretation
protocols and hybrid imaging techniques, there is an added value of
nuclear medicine techniques, which are not only highly convenient for
the patient (non-invasive, one-stop-shop principle) but could even
lead to cost effectiveness by telling the clinician exactly when to
perform invasive techniques and when not.
Last year, an expert panel of nuclear medicine specialists, radiolo-
gists, orthopaedic surgeons and infectious disease specialists proposed
a diagnostic flow chart about when to use which technique at
which time point in patients with a suspicion of PJI [11]. This flow
chart should be the basis for further studies. Indeed, members of
the Infection and Inflammation Committee of the EANM are right
now, in collaboration with delegates from the European Society of
Radiology (ESR), the European Society of Clinical Microbiology and
Infectious Diseases (ESCMID) and the European Bone and Joint Infec-
tion Society (EBJIS) working on joint guidelines for the diagnosis of
PJI. We welcome the American Societies to join us in future efforts to
commonly make correct statements of how and when to use nuclear
medicine techniques.
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In Reply
We welcome the interest of our esteemed colleagues in our pub-
lished article entitled “Diagnosis of Periprosthetic Joint Infection: The
Role of Nuclear Medicine May Be Overestimated.”
The lack of uniformity in the diagnosis of periprosthetic joint infection
(PJI) [1] and the variability in reporting the outcome of treatment of this
disease [2] continue to be an issue in the field of orthopedics. The Infec-
tion and Inflammation Committee of the European Association of Nuclear
Medicine should be congratulated for their effort to decrease variability in
performing bone scan imaging and interpreting the results of this test. It
can certainly be beneficial to patients, clinicians, and researchers.
The authors raise some specific points regarding our publication that
wewould like to address. Our interpretation of “concrete evidence to sup-
port the use of any given diagnostic tool for PJI” not only depends on the
results published as a percentage of accuracy, but the relevance with
which that evidence is weighted when compared to other tools. That
fact represents the strongest manifestation of a tangible clinical value. In
consequence, “concrete evidence” becomes, from our standpoint, a syno-
nym of support for clinical usefulness. Neither the American Academy of
Orthopaedic Surgeons guidelines [3] nor the International Consensus
Meeting (ICM) onPJI [4] recommends the use of nuclearmedicine studies
for the diagnosis of PJI. A large percentage of the delegates (93%) at the
ICM felt that there was no direct role for bone scans in the diagnosis of
PJI. This most probably reflects the experience of the majority of experts
in thefield of orthopedics andwhat is reflected in the literature, as detect-
ed by our study, in that bone scans usually provide inconclusive data that
cannot be directly employed in reaching or refuting the diagnosis of PJI.
Glaudemans et al also stated “Most of the papers analyzed by Diaz-
Ledezma et al. have not used a correct imaging protocol or standardized
interpretation criteria.” This is indeed a very sobering statement as it im-
plies that studies in the field of nuclear medicine regarding PJI have suf-
fered from serious shortfalls, and this leaves one to wonder why these
studies ever found their way into the literature.
One ormore of the authors of this paper have disclosed potential or pertinent conflicts
of interest, which may include receipt of payment, either direct or indirect, institutional
support, or association with an entity in the biomedical field which may be perceived to
have potential conflict of interest with this work. For full disclosure statements refer to
http://dx.doi.org/10.1016/j.arth.2015.07.004.
Downloaded for Anonymous User (n/a) at University of Groningen from ClinicalKey.com by Elsevier on June 12, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
